A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2002
12/25/2002	CN1387577A Process for producing product contg. antihypertensive tripeptides
12/25/2002	CN1387576A Sequence-specific DNA recombination in ekaryotic cells
12/25/2002	CN1387568A Modified ciliary neurotrophic factor, method of making and methods of use thereof
12/25/2002	CN1387565A Hematopoietic differentiation of human embryonic stem cells
12/25/2002	CN1387564A Lactobacillus helvetius producing antihypertensive di- and tripeptides
12/25/2002	CN1387442A Oral recombinant lactobacilli vaccines
12/25/2002	CN1386531A Chinese medicine for treating syringomyelia
12/25/2002	CN1386520A Chinese medicine composition for treating acute mastitis, mastroplasia and hysteromyoma
12/25/2002	CN1386511A Medicine for preventing and treating senile dementia
12/25/2002	CN1386510A Composition of suppressing infection, and veberage and food contg. same
12/25/2002	CN1386509A Process for preparing colostrum from pig's antibody serum for piglet
12/25/2002	CN1096865C Chinese patent medicine for traeting diabets
12/25/2002	CN1096864C Active royal jelly lozenge and method for preparing same
12/24/2002	US6498234 Compounds
12/24/2002	US6498233 Nucleic acid transfer system
12/24/2002	US6498181 Enhancing humoral immune response in combination with cancer therapy including surgery, radiation and immunotherapy
12/24/2002	US6498149 Culturing human placental decidua derived cells with surface markers as positive cd57 and bright hla.dr; 1-dehydroxy-2-(1-guanine, 1-uracil or 1-(7-ketopurine))ribofuranose deri-vatives; reduced side effects
12/24/2002	US6498018 Cultures of human CNS neural stem cells
12/24/2002	US6498007 Methods of treatment of disease using adsorbent carriers
12/24/2002	US6497875 Multilayer skin equivalent consisting of scaffold layer incorporated with dermis-forming cells consisting of mesenchymal stem cells, and keratinocyte layer; treating burns and ulcers
12/24/2002	US6497874 Modified filamentous phage which retains ability to bind and infect helicobacter pylori
12/24/2002	US6497873 Rhabdovirus comprising heterologous fusion protein which facilitates fusion of rhabdovirus to target cell membrane, heterologous g stem polypeptide, rhabdovirus n, p and l proteins, deletion of nucleotide sequence encoding g protein
12/24/2002	US6497872 Neural transplantation using proliferated multipotent neural stem cells and their progeny
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2065404C Assays and reagents for amyloid deposition
12/19/2002	WO2002101388A2 Assay for predeicting cell activity
12/19/2002	WO2002101385A1 In vivo bioreactors
12/19/2002	WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002	WO2002101056A2 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101030A1 Method f0r the isolation of a cluster of cells from an isolated organ
12/19/2002	WO2002101029A1 Method of separating and concentrating cells for kidney regfneration
12/19/2002	WO2002101021A2 Purification of human serum albumin
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100421A1 Low molecular weight components of cartilage, complexes of copper with amino acids or di-peptides; processes for preparation and therapeutic uses thereof
12/19/2002	WO2002100420A2 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne
12/19/2002	WO2002100335A2 Methods for improving cell line activity in immunoisolation devices
12/19/2002	WO2002082904A3 Method of treating or retarding the development of blindness
12/19/2002	WO2002081677A3 Improved gene expression
12/19/2002	WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002	WO2002072429A9 Albumin in a flexible polymeric container
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002	WO2002045723A9 Inflammatory cytokine secretion inhibition with modified mammalian blood
12/19/2002	WO2001072994A9 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
12/19/2002	US20020194638 Vector for genetically modifying non-human animals
12/19/2002	US20020194637 Generation of genetic engineered embryonic stem cells for use in the treatment of parkinson's, huntington's, alzheimer's, diabetes, multiple sclerosis, muscular, bone and liver disorders
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020194631 Method of treating psoriasis using anti-interleukin 12 antibody
12/19/2002	US20020193561 P53 protein variants and therapeutic uses thereof
12/19/2002	US20020193416 Synergistic tumorcidal response induced by histamine
12/19/2002	US20020193350 Contacting a sample containing sperm with a solution comprising a polysaccharide containing arabinose, galactose and/or hexuronic acid (PCAGH) to form a mixture, wherein the PCAGH is not arabinogalactan; separating sperm from the sample
12/19/2002	US20020193327 For therapy of eye disorders including retinitis pigmentosa, Stargardt's disease, diabetic retinopathies, retinal vascularization, or retinoblastoma
12/19/2002	US20020193317 Using smilagenin, prazerigenin, an astragaloside, tigogenin, ruscogenin, hecogenin and diosgenin in manufacture of medicament for therayp of condition characterised by deficiency in postsynaptic membrane-bound receptor number
12/19/2002	US20020193316 Caloporoside derivatives, methods of their preparation and use
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193308 Recombinant protein and its use in therapy and diagnostics
12/19/2002	US20020193296 Vaccines; therapy; prophylaxis
12/19/2002	US20020192816 Human pancreatic progenitor cells for use in cell therapy
12/19/2002	US20020192681 Detection of parasite in sample; obtain sample, isolate nucleotide sequences from dendritic cells, determine gene expression, presence of preferential gene indicates infections
12/19/2002	US20020192632 Method and devices for the removal of psoralens from blood products
12/19/2002	US20020192334 Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
12/19/2002	US20020192263 Allograft bone composition having a gelatin binder
12/19/2002	US20020192238 Proceture to use staphylococcal bacteria
12/19/2002	US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002	US20020192228 Protein markers for lung cancer and use thereof
12/19/2002	US20020192202 Probiotic compounds derived from lactobacillus casei strain KE01
12/19/2002	US20020192200 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
12/19/2002	US20020192199 Composition and methods for enhanced tumor cell immunity in vivo
12/19/2002	US20020192198 Method for growing human organs and suborgans
12/19/2002	US20020192196 Method and composition for skin grafts
12/19/2002	US20020192194 Production and use of dopaminergic cells to treat dopaminergic deficiencies
12/19/2002	US20020192193 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192192 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192190 Induction of immunological tolerance
12/19/2002	US20020192189 AAV transduction of myoblasts
12/19/2002	US20020192187 Gene transfer with adenoviruses having modified fiber proteins
12/19/2002	US20020192186 Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase
12/19/2002	CA2852202A1 Calcium phosphate delivery vehicles for osteoinductive proteins
12/19/2002	CA2450720A1 In vivo bioreactors
12/19/2002	CA2450036A1 Assay for predicting cell activity
12/19/2002	CA2449598A1 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
12/19/2002	CA2448432A1 Purification of human serum albumin
12/19/2002	CA2447763A1 Methods for improving cell line activity in immunoisolation devices
12/19/2002	CA2447658A1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/18/2002	EP1266666A2 Fibrin sealant compositions and method for utilizing same
12/18/2002	EP1266022A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266009A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF
12/18/2002	EP1265987A2 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same
12/18/2002	EP1265986A2 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material
12/18/2002	EP1265985A1 Pancreatic islet cell growth factors
12/18/2002	EP1265983A1 Particles containing coated living micro-organisms, and method for producing same
12/18/2002	EP1265915A2 Novel compounds
12/18/2002	EP1265637A2 Compositions and methods for affecting osteogenesis
12/18/2002	EP1265624A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof
12/18/2002	EP1265596A2 Medical emulsion for lubrication and delivery of drugs

1 ... 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 ... 1259